Business
Archived — This article has been archived. The information may be outdated.
Amrutanjan targets 100,000 direct chemist outlets in FY27
Business Standard··31 Aug
Amrutanjan Health Care plans to reach 100,000 direct chemist outlets in FY27 after adding 44,000 outlets in FY26, CMD S Sambhu Prasad said. Revenue from operations rose 11.23 percent to Rs 502.55 crore in FY26. Net profit grew nearly 14 percent to Rs 57.92 crore. Pain management gross sales grew 10 percent. The firm employs over 650 people.
Prism
What It Means For You
- Outlets beyond Amrutanjan's south and east strongholds are next for direct distribution growth.
- Shoppers may see the Relief congestion brand return during the current fiscal year.
- Investors get FY26 revenue of Rs 502.55 crore and net profit of Rs 57.92 crore.
What's Happening
- Prasad said the 100,000 direct chemist goal will be met in FY27.
- Comfy holds 4th place nationally in the mass pad segment after its 2013 launch.
- The company said 70 percent of critical processes are automated.
What Changes For Chemists
- FY26 growth was led by Amrutanjan and Comfy in pain and women's hygiene.
- Rural distribution and low-price packs deepened core markets.
- Amrutanjan also flagged brand launches on Amazon USA and Amazon India.
all-news
